XBiotech Inc. (XBIT)
NASDAQ · Healthcare
XBiotech Inc. Shareholder Equity 2018–2023
XBiotech Inc. annual shareholder equity history from 2018 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- XBiotech Inc. shareholder equity as of December 31, 2023: 218.8M, a 8.97% decrease year-over-year.
- XBiotech Inc. shareholder equity for 2023 were 218.8M, a 8.97% decrease from 2022.
- XBiotech Inc. shareholder equity for 2022 were 240.4M, a 10.76% decrease from 2021.
- XBiotech Inc. shareholder equity for 2021 were 269.4M, a 22.73% decrease from 2020.
- XBiotech Inc. shareholder equity for 2020 were 348.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| XBiotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $219 |
| 2022 | $240 |
| 2021 | $269 |
| 2020 | $349 |
| 2019 | $756 |
| 2018 | $41 |
XBiotech Inc. Shareholder Equity — FAQ
XBiotech Inc. (XBIT) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XBIT's shareholder equity history?
The chart and table above show XBiotech Inc.'s shareholder equity by year and by quarter, including the growth rate.